Study: Real-world results of GLP-1 drugs don't match trials
Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised by the drugs' clinical trials, a new study says.
People taking such GLP-1 drugs lost just under 9% of their body weight on average after a year, researchers reported Tuesday in the journal Obesity.
That's far less than the 15% to 21% body weight reduction promised by the clinical trials that led to the approval of Wegovy (semaglutide) and Zepbound (tirzepatide) for weight loss, researchers said.
"Patients treated for obesity with semaglutide or trizepatide lost less weight on average in a regular clinical setting compared to what is observed in randomized clinical trial," lead investigator Hamlet Gasoyan said in a news release. He is a researcher at the Cleveland Clinic Center for Value-Based Care Research.
People taking the drugs in real-world settings appear to be more likely to quit taking the meds, researchers said. They also might be prescribed lower dosages in clinical practice than were used in the drug trials.
Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food.
For this study, researchers tracked nearly 7,900 patients being treated by the Cleveland Clinic for severe obesity, of whom about 6,100 were prescribed semaglutide and the rest tirzepatide.
Average body weight loss after a year was nearly 9% for the whole group, results show.
But weight loss varied based on when a person stopped taking the drugs, researchers found.
Average weight loss was under 4% for those who stopped treatment early, versus nearly 7% or those who stopped later on, the study says. Those who stayed on their medications lost an average 12% body weight.
Results also show that more than 4 in 5 (81%) of patients were prescribed a low maintenance dose of their GLP-1 drug, and that made a difference as well.
People who stayed on their meds and received high doses lost nearly 14% of their body weight with semaglutide and 18% with tirzepatide.
"Our findings about the real-world use patterns of these medications and associated clinical outcomes could inform the decisions of health care providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions," Gasoyan said.
Overall, patients had higher odds of losing 10% or more of their body weight after a year if they remained on their meds, were prescribed a high dosage, were taking tirzepatide rather than semaglutide, and were female, results show.
The cost of the drugs and problems were insurance were a common reason for patients stopping GLP-1 treatment, along with side effects and medication shortages, researchers said.
Staying on the GLP-1 meds particularly helped the nearly 17% of patients who had prediabetes, a condition in which elevated blood sugar levels increase a person's risk of developing Type 2 diabetes.
About 68% of those who stuck with their treatment wound up with normal blood sugar levels, compared with 41% who stopped taking the drugs later in the study and 33% who stopped earlier.
"Type 2 diabetes is one of the most common complications of obesity, so diabetes prevention is very important," Gasoyan said. "This study highlights that treatment discontinuation, especially early, negatively affects both weight and glycemic control outcomes."
A follow-up study is in the works to better track why patients stop taking their GLP-1 drugs, researchers said.
More information
Harvard Medical School has more on GLP-1 drugs.
Copyright © 2025 HealthDay. All rights reserved.
Copyright 2025 UPI News Corporation. All Rights Reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Dietitian Who Lost 60 Pounds With GLP-1 Drug Reveals Foods to Avoid and Prioritize
Jennifer Lynn-Pullman is a certified specialist in obesity and weight management, so she was frustrated when her own weight kept rising over the years. 'I had struggled with my weight for a long time. My whole family struggles as well, so it's very genetic,' Lynn-Pullman, 48, a registered dietitian and manager of clinical dietetics for Vida Health, tells "And of course, in your 40s with perimenopause, it doesn't get any easier.' Lynn-Pullman, who lives in suburban Philadelphia, was alarmed when her cholesterol went up for the first time two years ago and her A1C — a measure of blood sugar — was trending up. At 5 feet, 6 inches tall, she weighed 200 pounds and worried she was on track to develop Type 2 diabetes in her 50s like her parents. Her doctor prescribed Wegovy, the version of Ozempic approved for weight loss. It's part of the GLP-1 class of medications that mimic a hormone the body produces after eating to decrease appetite and help the body manage insulin production. After starting the drug in 2023, Lynn-Pullman lost 60 pounds in 10 months and has maintained that weight for more than a year. Like many patients, she experienced side effects and had to figure out which foods to avoid on a GLP-1 and how to prevent muscle loss. Here are her tips for eating on a GLP-1 based on her own experience: Lynn-Pullman had side effects for the first six months, usually when her medication dosage was increased. GLP-1 drugs slow stomach emptying, one of the reasons patients can experience uncomfortable symptoms. Nausea and vomiting are some of the most common side effects. For nausea, Lynn-Pullman prefers to use ginger gum. She also prepares easy to digest foods like a smoothie, soup and crackers that aren't too heavy for her stomach. Vomiting is usually due to eating too much or consuming high-fat foods, so she advises eating smaller meals, not eating too fast and avoiding greasy foods. 'Fat just stays in your stomach longer,' she says. 'With someone whose stomach is emptying much slower, it causes more of an upset.' Lynn-Pullman realized her vomiting episodes were caused by high-fiber muffins she was eating to help ease constipation. Once she cut them out, the problem stopped. The dietitian decided to treat herself like her bariatric surgery patients. 'I realized that because Wegovy causes such an increased level of satiety and such a long level of fullness, that it was very similar to those patients,' she says. Lynn-Pullman eats very small frequent meals she sometimes calls 'eating episodes.' She eats a higher-protein diet to help combat any muscle loss. She has protein every time she eats, consuming that food first, then fruits and vegetables. Any starchy food is last, if there's even room for it. Since liquid fills up the stomach, she suggests not drinking beverages with meals to get enough food in, then hydrating between meals. Here's her typical daily menu: Breakfast: A protein shake, cereal with fiber and ultrafiltered milk, which contains more protein than regular milk. Lunch: A turkey sandwich or salad topped with chicken. Dinner: Chicken or salmon with a vegetable. She occasionally eats rice or pasta on the side, but it fills her up too much, so she usually skips it. Snacks: An apple with peanut butter or nuts with a piece of fruit. Lynn-Pullman always loved sweets, noting she couldn't pass up a cookie or a piece of chocolate, especially in the afternoon. But after she began using Wegovy, she stopped craving sugar. 'It was the most miraculous thing,' Lynn-Pullman recalls. 'The food noise, that inner voice saying, 'Go get something sweet' — it vanished.' Today, she occasionally eats dark chocolate or might split a dessert with her husband if she goes out to dinner, but mostly skips sweets. When it comes to alcohol, she has a drink 'once in a blue moon if she goes to a party." 'The thing that I worry about is being nauseous or even feeling dehydrated the next day,' Lynn-Pullman says. 'We usually suggest that patients refrain from it just because of all of those potential side effects.' The dietitian works out three times a week, focusing on weight training to minimize muscle loss. Three months after starting Wegovy, Lynn-Pullman noticed she was cold all the time, even in the August summer heat. She began journaling her food intake and discovered she was eating only 800 calories a day, with very little protein. 'It's easy to do on a GLP-1 because you don't feel hungry and you fill up quickly,' Lynn-Pullman says. 'We worry about malnutrition, we worry about people not getting enough nutrients.' When she started eating more protein and calories, her symptoms went away quickly. That's why it's important to work with a dietitian and report symptoms like feeling cold, tired or exhausted, or noticing hair loss — potential symptoms of eating too little, Lynn-Pullman notes. This article was originally published on
Yahoo
8 hours ago
- Yahoo
Novo Nordisk announces WeightWatchers collaboration for Wegovy
Novo Nordisk (NVO) said it expanded patient access to Wegovy through a new collaboration with WeightWatchers, beginning July 1. WeightWatchers will work with CenterWell Pharmacy as the dispensing pharmacy managing prescription fulfilment and delivery for NovoCare Pharmacy. 'By extending access to Wegovy through their integrated support system, WeightWatchers aims to provide patients with a more streamlined experience, along with convenient access to FDA-approved medication with the lifestyle support shown to improve outcomes,' the company said. Starting on July 1, Novo Nordisk is also introducing a new cash-offer price of $299 available through July 31. This $299 introductory price is available for self-paying patients who are new to the Wegovy savings offer or those who have not previously filled a prescription through NovoCare Pharmacy. This builds on the previous $199 Wegovy cash-offer patient price that expires on June 30, Novo added. Patients who redeemed the $199 Wegovy savings offer between May 22 and June 30, will be eligible for the $299 price on one fill between July 1 and July 31. For subsequent months, self-paying patients will pay $499 per month. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on NVO: Disclaimer & DisclosureReport an Issue Is the Hims & Hers Stock (HIMS) Crash a Hidden Buying Opportunity? Citi sees tiered orforglipron pricing $15B opportunity for Eli Lilly Needham Downgrades Hims & Hers Stock (HIMS) on Novo Nordisk Fiasco. Wall Street Sees Legal Risks California seeks to cut Medicaid coverage for weight loss drugs, Bloomberg says Hims & Hers litigation risk 'back on the table', says Truist Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Times
11 hours ago
- New York Times
Is It Wrong to Push Ozempic on My Spouse?
My husband's lifestyle is very sedentary, with minimal exercise (20 to 60 minutes a week), though he does eat a largely healthy diet. I've watched him struggle with his weight over the 15 years we've been together, cycling through various approaches to diet and exercise. Even when he succeeds in losing weight, it always comes back, and now he seems to have given up. As we both approach 50, I worry that his B.M.I., which is 30, and his B.R.I. (body roundness index, a measure of abdominal fat) are high (he can't even button some of his shirts around the middle), which could lead to other health issues. I've already tried encouraging him to move more and eat better, but I can't schedule every one of my workouts for us to exercise together, and he dislikes some of the routines I do, anyway. He's also very sensitive about his weight. Is it wrong for me to try to get him to take Ozempic? I'm hoping that losing weight will help boost his energy levels, which might lead to more self-care. I know it's not my body, and I'm not his doctor, but as his wife I also know it will fall to me to care for him if health issues arise. — Name Withheld From the Ethicist: It's natural to worry about the health of someone you love — especially as the years accumulate and the lines between caring for yourself and caring for your partner begin to blur. Long-term relationships involve a particular kind of vigilance: You notice the wince, the shortened breath, the unbuttoned shirt. This isn't control; it's love in the form of everyday attention. Obesity really is correlated with health problems, and if your husband could lose weight sustainably, his life might improve in ways that matter. Historically, weight loss has been a story of perpetual disappointment — diets abandoned, exercise routines that peter out, New Year's resolutions that start wobbling the following evening when it becomes clear that celery sticks are an imperfect substitute for chocolates. GLP-1 drugs, such as Ozempic, have helped many people break that cycle. Still, even sound advice can land wrong if it touches a nerve. If your husband is sensitive about his weight, the real challenge isn't knowing what's best; it's finding a way to talk about it that feels loving, not critical. Try to keep the focus on the prospect of his feeling fitter and on your hope for more good years ahead. Maybe suggest he talk to his doctor — not as a directive but as a way to explore options. You're not pushing him to 'fix' himself; you're looking out for him. If it turns out to be a difficult conversation all the same? Loving someone can mean risking that discomfort — for the sake of all the days you haven't yet lived together. Want all of The Times? Subscribe.
